Opponents Of Gene Patents Fight On

Law360, New York (July 25, 2008, 12:00 AM EDT) -- Biotechnology companies have patented thousands of human genes over the last 30 years, but U.S. opponents of such patents are still hoping to challenge their legality, either through the courts or through an act of Congress.

Dan Ravicher, executive director of the Public Patent Foundation at the Benjamin N. Cardozo School of Law, said the U.S. Patent and Trademark Office allows the patenting of genes as long as they are isolated or purified.

He said there has yet to be a court case to strongly test...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.